Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Omicia and Johns Hopkins Receive Small Business Technology Transfer Grant from NIH

Published: Friday, August 17, 2007
Last Updated: Friday, August 17, 2007
Bookmark and Share
Omicia recieves a $187,700 grant from NIH to support a collaboration with Johns Hopkins University to identify genetic causes of cardiovascular disease.

Omicia, Inc. has been awarded its fourth NIH grant, a $182,732 Small Business Technology Transfer (STTR) Phase I grant from the National Heart, Lung, and Blood Institute of the National Institutes of Health.

This industry/academia collaboration between Omicia and Johns Hopkins University (JHU) will be headed by Principal Investigator Dr. Joel Bader, an Assistant Professor of Biomedical Engineering at JHU.

Drawing upon Omicias advanced understanding of disease genes and phenotypes and Dr. Baders expertise in gene interaction networks and model organism genetics, the project will identify genes whose variants increase the risk of developing cardiovascular disease.

Dr. Bader and Omicia aim to elucidate the genetic risk factors for cardiovascular disease in humans by drawing parallels from systematic genetic screens performed on fruit flies and other model organisms.

The goal of these screens is to determine phenotypes (observable physical characteristics) for every relevant gene in each of the targeted model organisms. In this funded collaboration, data mining algorithms will be developed to select sets of genes, or modules, that give rise to similar phenotypes across the range of model organisms. These conserved modules are likely to play significant roles in human health and disease.

"This project will give us the opportunity to apply the latest findings in genetic research to the challenging problem of figuring out the molecular causes of complex diseases," said Dr. Bader, who is an inventor on the patent for the new high-speed 454 DNA sequencing technology that was recently used to completely sequence the first individual human genome.

"By combining our research group's experience in analyzing gene interactions with Omicia's cutting-edge gene selection infrastructure, we aim to significantly advance the understanding of the genetic basis of cardiovascular disease, paving the way towards the earliest possible diagnosis and the most appropriate therapeutic options."


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,200+ scientific posters on ePosters
  • More than 4,600+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Tumor-Only Genetic Sequencing May Misguide Cancer Treatment in Nearly Half of All Patients
Johns Hopkins scientists say the genetic code of tumors must be compared to patients’ noncancer genome to get a true picture.
Thursday, April 16, 2015
New Genetic and Epigenetic Contributors to Diabetes Identified
Comparison of fat cells in mice and men hints at how genes and environment conspire to produce disease.
Wednesday, January 07, 2015
When DNA Gets Sent to Time-Out
New details revealed in the coordinated regulation of large stretches of DNA.
Tuesday, January 06, 2015
CRISPR Shows Promise in Engineering Human Stem Cells
Johns Hopkins study could advance use of stem cells for treatment and disease research.
Monday, January 05, 2015
Up-close Look at Cancer on the Move
Microscopic view of metastasis could give insight about how to keep cancer in check.
Friday, November 07, 2014
Potential New 'Twist' in Breast Cancer Detection
Mouse studies reveal new and better picture of stem cells that may fuel some breast cancers.
Monday, December 07, 2009
Johns Hopkins Researchers Develop Human Stem Cell Line Containing Sickle Cell Anemia Mutation
Researchers establish a human cell-based system for studying the disease by reprogramming somatic cells to an embryonic stem cell like state.
Tuesday, June 03, 2008
Johns Hopkins Researcher Leads International Effort to Create “Proteinpedia”
A Johns Hopkins researcher has led the effort to compile to date the largest free resource of experimental information about human proteins.
Thursday, February 07, 2008
RNA Shown to Silence Cancer Suppressor Gene
Discovery sheds light on epigenetic mechanisms in tumor development in plants and animals.
Tuesday, January 15, 2008
Cellular Pump Sabotages Cancer Drug Studies that use Glow Chemical
Scientists discover that a widely used means of illuminating cancer cells could undermine studies of the potential value of experimental anti-cancer drugs.
Thursday, January 03, 2008
More Functional DNA in Genome than Previously Thought
Hopkins researchers report that non-coding DNA, that contributes to inherited diseases like Parkinson’s or mental disorders, may be more abundant than we realize.
Thursday, December 20, 2007
Key to Lung Cancer Chemo Resistance Revealed
Products made by a gene called NRF2 normally protect cells from environmental pollutants.
Tuesday, October 17, 2006
Scientific News
Benchtop Automation Trends
Gain a better understanding of current interest in and future deployment of benchtop automated systems.
Higher Frequency of Huntington's Disease Mutations Discovered
University of Aberdeen study shows that the gene change that causes Huntington's disease is much more common than previously thought.
Revealing the Genetic Causes of Bowel Cancer
A landmark study has given the most detailed picture yet of the genetics of bowel cancer — the UK's fourth most common cancer.
The Epigenetic Influences of Chronic Pain
Researchers at Drexel University College of Medicine are aiming to identify new molecular mechanisms involved in pain.
Fighting Resistant Blood Cancer Cells
Biologists present new findings on chronic myeloid leukemia and possible therapeutic approaches.
Tumor Cells Develop Predictable Characteristics
Scientists have discovered that cancer cells at the edge of a tumor that are close to the surrounding environment are predictably different from the cells within the interior of the tumor.
Mothers Obesity Could be Passed on in mtDNA
Obesity can predispose offspring in multiple generations to metabolic problems.
New Imaging Method Reveals Nanoscale Details about DNA
Enhancement to super-resolution microscopy shows orientation of individual molecules, providing a new window into DNA’s structure and dynamics.
Genetic Research Can Significantly Improve Drug Development
With drug development costs topping $1.2bn (£850 million) to get a single treatment to the point it can be sold and used in the clinic, could genetic analysis save hundreds of millions of dollars?
Naked Mole Rat Exhibits “Extraordinary” Cancer Resistance
Scientists are getting closer to understanding the anti-cancer mechanism of the naked mole rat by making induced pluripotent stem cells.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,600+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!